Asciminib Roll-over Study

Condition:   Chronic Myelogenous Leukemia Interventions:   Drug: Asciminib single agent;   Drug: Asciminib;   Drug: Imatinib;   Drug: Nilotinib;   Drug: Bosutinib;   Procedure: ECG;   Procedure: Pregnancy test Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials